Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000950170-25-094107·GoodRx Holdings, Inc.
Schedule 13D ownership disclosure
GoodRx Holdings Inc
Class A Common Stock · CUSIP: 38246G108
Event date: 2025-07-02
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Spectrum Equity VII, L.P.Reported CIK 0001609969
Shares: 14,865,346 · Class: 12.9%
- Spectrum Equity Associates VII, L.P.Reported CIK 0001824228
Shares: 14,865,346 · Class: 12.9%
- Spectrum VII Investment Managers' Fund, L.P.Reported CIK 0001626997
Shares: 25,445 · Class: 0.02%
- Spectrum VII Co-Investment Fund, L.P.Reported CIK 0001822087
Shares: 14,342 · Class: 0.01%
- SEA VII Management, LLCReported CIK 0001824265
Shares: 14,905,133 · Class: 12.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-094107
- Form type
- SCHEDULE 13D/A
- Filer
- GoodRx Holdings, Inc.
- CIK
- CIK 1809519
- Filed
- Jul 03, 2025
- Reporting period
- Jul 02, 2025
- Description
- Schedule 13D beneficial ownership